Oncodesign Services

Foundation date

05/01/1995

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Oncodesign is a biopharma company dedicated to the precision medicine. Oncodesign is able to predict and identify, at a very early stage, each molecule's therapeutic usefulness and potential to become an effective drug. Applied to kinase inhibitors, Oncodesign’s technology has already enabled the targeting of several promising molecules with substantial therapeutic potential, in oncology and elsewhere, along with partnerships with pharmaceutical groups such as Bristol-Myers Squibb and UCB.

Latest news

  • Waste2Func Video Release: The technology is ready, are we?

    Friday May 24th 2024

  • BIO INX and Readily3D Announce Collaboration to Advance Volumetric Bioprinting with Cutting-edge Gel-MA Based Ink

    Wednesday May 22nd 2024

  • Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®

    Wednesday May 22nd 2024